Prof Dr Stephan Jacob, Germany
Show CV

Stephan Jacob is an endocrinologist, diabetologist, nutrition expert, and clinical hypertension specialist in private practice. He has established a cardiometabolic institute (CMI) to coordinate the outpatient care of cardiometabolic patients, including non-pharmacological and pharmacological therapy, lifestyle coaching, and is involved in setting up a network between family doctors and clinics in his town. He also teaches at the University of Tübingen, Tübingen, Germany.

Previously, he was a Senior Consultant in the Department of Endocrinology, Metabolism, and Pathobiochemistry at the University of Tübingen (Prof. Dr. Häring). Professor Jacob’s research interests include the cardiometabolic syndrome and the role of early detection and intervention. Specifically, he is interested in the effects of lifestyle intervention on the prevention and evidence-based medical treatment of comorbidities, as well as how to set up structured care in an outpatient setting (CMI) where all these points are coordinated.

Another interest is the global burden of the cardiometabolic syndrome on societies, especially in the poorer areas of the world, where health education, early diagnosis, and lifestyle intervention should be supported. Professor Jacob is on the board of both the Working Group on Diabetes and Heart and the working group on Prevention of Diabetes of the German Diabetes Association. He also heads the research group on cardiometabolic care at the University of Munich in Munich, Germany. Additionally, he is a founding fellow of the Specialist Certification of Obesity Professional Education (SCOPE).

Professor Jacob is a member of several guideline committees and editorial boards. He is involved in several cardiovascular outcome trials of new antidiabetic medications and is a frequent lecturer with a specific focus on cardiometabolic risk management. He does this worldwide, preferably at face-to-face meetings, to meet and exchange information with colleagues throughout the world. His main interest is to help translate evidence (such as that of the big CVOT) into clinical practice and help change the mindset in diabetes management from sugarology to cardio-(reno-)metabolic prevention!